SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/259718"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/259718" > Mechanism and prope...

Mechanism and properties of positive allosteric modulation of N-methyl-D-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives

Sapkota, K. (författare)
Irvine, M. W. (författare)
Fang, G. Y. (författare)
visa fler...
Burnell, E. S. (författare)
Bannister, N. (författare)
Volianskis, A. (författare)
Culley, Georgia, 1988 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology
Dravid, S. M. (författare)
Collingridge, G. L. (författare)
Jane, D. E. (författare)
Monaghan, D. T. (författare)
visa färre...
 (creator_code:org_t)
Elsevier BV, 2017
2017
Engelska.
Ingår i: Neuropharmacology. - : Elsevier BV. - 0028-3908. ; 125, s. 64-79
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The theory that N-methyl-D-aspartate receptor (NMDAR) hypofunction is responsible for the symptoms of schizophrenia is well supported by many pharmacological and genetic studies. Accordingly, positive allosteric modulators (PAMs) that augment NMDAR signaling may be useful for treating schizophrenia. Previously we have identified several NMDAR PAMs containing a carboxylic acid attached to naphthalene, phenanthrene, or coumarin ring systems. In this study, we describe several functional and mechanistic properties of UBP684, a 2-naphthoic acid derivative, which robustly potentiates agonist responses at each of the four GluN1a/GluN2 receptors and at neuronal NMDARs. UBP684 increases the maximal L-glutamate/glycine response while having minor subunit-specific effects on agonist potency. PAM binding is independent of agonist binding, and PAM activity is independent of membrane voltage, redox state, and the GIuN1 exon 5 N-terminal insert. UBP684 activity is, however, markedly pH-dependent, with greater potentiation occurring at lower pHs and inhibitory activity at pH 8.4. UBP684 increases channel open probability (P-o) and slows receptor deactivation time upon removal of L-glutamate, but not glycine. The structurally related PAM, UBP753, reproduced most of these findings, but did not prolong agonist removal deactivation time. Studies using cysteine mutants to lock the GluN1 and GluN2 ligand-binding domains (LBDs) in the agonist-bound states indicate that PAM potentiation requires GluN2 LBD conformational flexibility. Together, these findings suggest that UBP684 and UBP753 stabilize the GluN2 LBD in an active conformation and thereby increase P-o. Thus, UBP684 and UBP753 may serve as lead compounds for developing agents to enhance NMDAR activity in disorders associated with NMDAR hypofunction. (C) 2017 Elsevier Ltd. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

L-glutamate
N-methyl-D-aspartate
Potentiator
Positive allosteric modulator
Deactivation
Ligand-
subunit messenger-rnas
nmda receptor
pregnenolone sulfate
glutamate-receptor
proton sensitivity
postmortem brains
schizophrenia
channel
recombinant
expression
Neurosciences & Neurology
Pharmacology & Pharmacy
esler m
1992
trends in neurosciences
v15
p396
shina m
1993
molecular basis of ion channels and receptors involved in nerve

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy